PAR DRUGS AND CHEMICALS
Back to Balance Sheet
|
PAR DRUGS AND CHEMICALS Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹3.48 Cr | ₹3.85 Cr | ₹3.54 Cr | ₹3.64 Cr | ₹3.96 Cr |
What is the latest Total Non-Current Liabilities ratio of PAR DRUGS AND CHEMICALS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹3.48 Cr |
| Mar2025 | ₹3.85 Cr |
| Mar2024 | ₹3.54 Cr |
| Mar2023 | ₹3.64 Cr |
| Mar2022 | ₹3.96 Cr |
How is Total Non-Current Liabilities of PAR DRUGS AND CHEMICALS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹3.48 Cr | -9.44 | |
| Mar2025 | ₹3.85 Cr | 8.67 | |
| Mar2024 | ₹3.54 Cr | -2.75 | |
| Mar2023 | ₹3.64 Cr | -7.99 | |
| Mar2022 | ₹3.96 Cr | - | |
Compare Total Non-Current Liabilities of peers of PAR DRUGS AND CHEMICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PAR DRUGS AND CHEMICALS | ₹141.0 Cr | 10% | -8.5% | 20% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,662.0 Cr | 2% | -4.4% | 3.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹257,903.0 Cr | 7.1% | 2.5% | 46.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,306.0 Cr | 1.4% | -5.7% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,699.0 Cr | 3.6% | 8% | 4.2% | Stock Analytics | |
| CIPLA | ₹111,489.0 Cr | 2% | -0.2% | -14.3% | Stock Analytics | |
PAR DRUGS AND CHEMICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PAR DRUGS AND CHEMICALS | 10% |
-8.5% |
20% |
| SENSEX | 1.8% |
2.3% |
-11.9% |
You may also like the below Video Courses